Reminder - Guggenheim Strategic Opportunities Fund (GOF) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 8/13/13, Guggenheim Strategic Opportunities Fund (GOF) will trade ex-dividend, for its monthly dividend of $0.1821, payable on 8/30/13. As a percentage of GOF's recent stock price of $21.60, this dividend works out to approximately 0.84%, so look for shares of Guggenheim Strategic Opportunities Fund to trade 0.84% lower — all else being equal — when GOF shares open for trading on 8/13/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for GOF, showing historical dividends prior to the most recent $0.1821 declared by Guggenheim Strategic Opportunities Fund:

GOF+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from GOF is likely to continue, and whether the current estimated yield of 10.12% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of GOF shares, versus its 200 day moving average:

Guggenheim Strategic Opportunities Fund 200 Day Moving Average Chart

Looking at the chart above, GOF's low point in its 52 week range is $19.85 per share, with $24.14 as the 52 week high point — that compares with a last trade of $21.52.

In Friday trading, Guggenheim Strategic Opportunities Fund shares are currently down about 0.2% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says